The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer-Reference-Cited by-同舟云学术

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

Published:2018-06-07 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Vernieri Claudio,Mennitto Alessia,Prisciandaro Michele,Huber Veronica,Milano Monica,Rinaldi Lucia,Cona Maria Silvia,Maggi Claudia,Ferrari Benvenuto,Manoukian Siranoush,Mariani Gabriella,Bianchi Giulia,Capri Giuseppe,Rivoltini Licia,de Braud Filippo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-27075-z.pdf

Reference38 articles.

1. Society, A. C. Cancer Facts & Figures. American Cancer Society, Atlanta (2017).

2. Malorni, L. et al. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res Treat 136(3), 795–804 (2012).

3. Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11), 674–690 (2016).

4. O’Shaughnessy, J. et al. Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer. J Clin Oncol 32(34), 3840–3847 (2014).

5. Yardley, D. C. R. et al. nab -paclitaxel + carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial. Abstract P5-15-03 Presented at: 2016 San Antonio Breast Cancer Symposium, San Antonio (2016).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of absolute lymphocyte count and neutrophil‐to‐lymphocyte ratio for patients with metastatic breast cancer: a systematic review and meta‐analysis;Frontiers in Oncology;2024-03-07

2. Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer;The Oncologist;2024-03-02

3. A nomogram for intraoperatively predicting non-sentinel lymph node metastases in early breast cancer patients with positive sentinel lymph nodes;Gland Surgery;2023-06

4. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison;Clinical Breast Cancer;2023-04

5. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Predictive Factors for Mortality and Length of Hospital Stay after Cardiac Surgery;Journal of Personalized Medicine;2023-03-05